The neurotransmitter acetylcholine (ACh) has been accorded an important role in supporting learning and memory processes in the hippocampus. Cholinergic activity in the hippocampus is correlated with memory, and restoration of ACh in the hippocampus after disruption of the septohippocampal pathway is sufficient to rescue memory. However, selective ablation of cholinergic septohippocampal projections is largely without effect on hippocampal-dependent learning and memory processes. We consider the evidence underlying each of these statements, and the contradictions they pose for understanding the functional role of hippocampal ACh in memory. We suggest that although hippocampal ACh is involved in memory in the intact brain, it is not necessary for many aspects of hippocampal memory function.
The goal of this review is to consider the role of septohippocampal acetylcholine (ACh) in learning and memory processes. The evidence in this regard falls broadly into two different classes. On the one hand, considerable data implicate septohippocampal ACh in memory function. This system is engaged during memory processing, indexed by ACh release or by modification of cholinergic markers, and manipulations that affect memory produce parallel changes in hippocampal cholinergic activity. Furthermore, agents that increase hippocampal cholinergic function are sufficient to reverse memory impairments caused by disruption of the septohippocampal system. However, data from studies of selective lesions of septohippocampal cholinergic neurons with the immunotoxin 192 IgG-saporin call into question the essential role of this system in learning and memory, because these studies generally failed to find severe impairments in memory function. Our goal in this article is to review the data underlying each of these lines of evidence, and to attempt to reconcile these apparently disparate observations.
The discrepancy between these lines of evidence might imply that septohippocampal ACh is involved in memory processing, but is not necessary for it to occur. This viewpoint would allow for correlated changes in ACh release and memory, and for the ability of cholinergic agents to reverse memory impairments caused by disruption of septohippocampal function. However, it also would permit memory to proceed relatively normally in the absence of septohippocampal cholinergic input. By describing this viewpoint and its implications for the functional role of hippocampal ACh in memory, we seek to promote the idea that data from lesions are compatible with data from other experimental approaches. Furthermore, we suggest that a convergent approach that incorporates observations from different experimental methods will reveal functional characteristics of hippocampal ACh that would not be apparent from studies using a single strategy.
Before discussing the role of this system in cognition, a brief review of its anatomical and neurochemical organization is warranted. The septum is connected to the hippocampus via the fimbria-fornix, which carries projections from the medial septum (MS, or Ch1) and the vertical limb of the diagonal band of Broca (VDB, or Ch2; Mesulam et al. 1983) . These projections are predominantly cholinergic and GABAergic (Lewis et al. 1967; Köhler et al. 1984; Rye et al. 1984) , although there are some neuropeptide projection neurons as well (Senut et al. 1989; Peterson and Shurlow 1992 ) and a putative glutamatergic projection (Sotty et al. 2003) . GABAergic receptors are present on cell bodies of both cholinergic and GABAergic septohippocampal projection neurons (Gao et al. 1995; Henderson 1995) . Likewise, muscarinic receptors are present on cell bodies of both cholinergic and GABAergic septohippocampal projection neurons (Van der Zee and Luiten 1994; Levey et al. 1995; Rouse and Levey 1996) . Septohippocampal GABAergic projections synapse onto GABAergic hippocampal interneurons (Freund and Antal 1988) , which in turn synapse onto pyramidal cells (Toth et al. 1997 ). Thus, GABAergic afferents to the hippocampus produce a net disinhibition of pyramidal cells. Cholinergic septohippocampal projections project broadly to the hippocampus, synapsing onto pyramidal cells, dentate granule cells, and inhibitory interneurons (Frotscher and Leranth 1985) . Lebrun et al. 1990; Durkin 1992 Durkin , 1994 Durkin and Toumane 1992; Galey et al. 1994 ). More recently, in vivo microdialysis has allowed for the ability to examine changes in hippocampal extracellular ACh levels in conscious, freely moving rats during behavioral tests of learning and memory. With few exceptions (e.g., Hironaka et al. 2001 ), the findings of such studies show that hippocampal-dependent learning and memory is associated with an increase in hippocampal extracellular ACh levels (Yamamuro et al. 1995; Fadda et al. 1996 Fadda et al. , 2000 Orsetti et al. 1996; Ragozzino et al. 1996 Ragozzino et al. , 1998 Stancampiano et al. 1999; Nail-Boucherie et al. 2000; Stefani and Gold 2001; McIntyre et al. 2002 McIntyre et al. , 2003 Chang and Gold 2003) . Combined, the findings of these studies show that hippocampal extracellular ACh is elevated by learning and memory processes, that the elevation is often correlated with the type of learning and memory or its time course, and that these increases cannot be accounted for solely by locomotor activity or by handling. It is important to stress that these data are correlational in nature and thus do not reveal whether ACh participates in, produces, or is necessary for learning and memory. Indeed, some authors have suggested that ACh might reflect a useful marker of the extent to which a structure is engaged in mnemonic processing, rather than reflecting a specific role for ACh itself in memory (McIntyre et al. 2002; Chang and Gold 2003) . This possibility is supported, for example, by the finding that hippocampal extracellular ACh levels increase in response to unconditioned or conditioned stimuli, but do not change when the same stimuli produce habituation (Acquas et al. 1996) .
Evidence Supporting the Involvement of Septohippocampal ACh in Memory

Hippocampal ACh Activity is Correlated With Memory
There are an overwhelming number of cases in which the effects of manipulations on memory are associated with their effects on hippocampal ACh function. For instance, aged rats that display memory deficits often display correlated decreases in hippocampal ACh markers (Lippa et al. 1980 (Lippa et al. , 1985 Sherman et al. 1981; Ikegami 1994; Scali et al. 1994; Aubert et al. 1995; Baxter et al. 1999b) . Chronic dietary restriction of choline (Nakamura et al. 2001) or vitamin A (Cocco et al. 2002) , and chronic alcohol consumption (Arendt et al. 1990; Melis et al. 1996) produce correlated deficits in memory and hippocampal ACh. Likewise, many systemic pharmacological treatments that impair memory decrease hippocampal ACh (Hersi et al. 1995; Nava et al. 2000 Nava et al. , 2001 Mishima et al. 2002) , whereas systemic drug treatments that enhance memory increase hippocampal ACh (Levy et al. 1991; Hersi et al. 1995; Scali et al. 1997a,b; Bontempi et al. 2001; Carey et al. 2001; Kopf et al. 2001) . Similar correlations are observed with intracerebroventricular (i.c.v.) manipulations (Scali et al. 1994; Hiramatsu et al. 1996; Choi et al. 2001; Olariu et al. 2001) .
More importantly, a wealth of studies shows that neurochemical manipulations in the septum produce parallel changes in memory and measures of hippocampal ACh. In some instances, the correlation is such that only those doses of a drug that affect memory are those that affect hippocampal ACh (e.g., Brioni et al. 1990) . Intraseptal infusions of GABA-A agonists (Brioni et al. 1990; Durkin 1992) , benzodiazepine (BZD) agonists (Herzog et al. 2000) , cholinergic antagonists (Givens and Olton 1990; Gorman et al. 1994) , opioid agonists (Ragozzino et al. 1992; Ragozzino and Gold 1995) , and noradrenergic antagonists ) impair various measures of memory and hippocampal ACh activity. Interestingly, manipulations that prevent septal pharmacologically induced memory deficits also prevent the concomitant changes in hippocampal ACh. Septal infusions of glucose prevent both opioid agonist-induced decreases in memory and extracellular hippocampal ACh levels (Ragozzino and Gold 1995) . Septal infusions of drugs that enhance memory, such as the neurosteroid pregnenolone sulfate (Darnaudery et al. 2002) , increase hippocampal ACh. A similar pattern of findings is observed with drug infusions into the hippocampus. For instance, infusions of glucose into the hippocampus increase hippocampal extracellular ACh levels and enhance memory (Ragozzino et al. 1998 ).
There are instances in which the effects of septal pharmacological manipulations on memory do not parallel their effects on hippocampal ACh. For instance, septal infusions of cholinergic agonists enhance memory or reverse memory deficits (Izquierdo et al. 1992; Givens and Olton 1995; cf. Markowska et al. 1995; Pang and Nocera 1999) , and would thus be expected to increase ACh function in the hippocampus. Instead, septal infusions of cholinergic agonists decrease hippocampal extracellular ACh levels (Gorman et al. 1994) . Similar dissociations are observed with BZD agonists. Septal infusions of two doses of the BZD agonist chlordiazepoxide produce comparable decreases in hippocampal HACU, but only the higher dose produces amnesia (Herzog et al. 2000) . Conversely, two doses of the BZD agonist zolpidem produce similar memory deficits when infused into the septum, but only one dose decreases HACU (Herzog et al. 2000) . Analogous dissociations have been observed in the hippocampus. Hippocampal infusions of compounds that modulate ATPsensitive potassium channels increase hippocampal ACh release regardless of whether they enhance or impair memory (Stefani and Gold 2001) . Combined, these dissociations between the neurochemical and behavioral measures raise questions about the role of hippocampal ACh in memory: Changes in memory can occur without commensurate changes in hippocampal ACh, and manipulations of the medial septum that impair memory need not necessarily affect markers of hippocampal cholinergic activity.
Upregulation of Hippocampal ACh Reverses Septal Memory Deficits
One line of research examines whether cognitive impairment after damage to or inactivation of the septum can be reversed by manipulations that increase cholinergic function. Overall, the evidence from these studies indicates that ACh is sufficient to improve mnemonic function. For example, implants of AChsecreting fibroblasts into the hippocampus attenuate cognitive deficits produced by unilateral fimbria-fornix lesions; implants into the frontal or parietal cortex are ineffective (DickinsonAnson et al. 1998) . Similarly, hippocampal grafts of fetal neuronal tissue rich in cholinergic neurons reverse memory deficits produced by a variety of manipulations, including septal lesions, hippocampal lesions, bilateral fimbria-fornix lesions, or selective 192 IgG-saporin-induced lesions of the septohippocampal ACh projection (Tarricone et al. 1996; Cassel et al. 1997 Cassel et al. , 2002 . Behavioral improvement is correlated with recovery of cholinergic markers Daniloff et al. 1985; Tarricone et al. 1991 Tarricone et al. , 1993 and prevented by systemic administration of cholinergic antagonists (Nilsson et al. 1987; Li et al. 1992 ). However, research using cholinergic grafts does not unequivocally implicate ACh in the recovery of memory. For instance, grafts can restore mnemonic function with little or no restoration of ACh levels or restore ACh levels without restoring cognitive function (Ipekoglu et al. 2000) . Grafts that have been shown to be functional often only result in partial restoration of memory Pallage et al. 1986; Tarricone et al. 1996) . Also, other features of cholinergic tissue grafts such as trophic factors or particular proteins may be responsible, at least in part, for functional recovery (Wets et al. 1991) .
Results from pharmacological studies also show that upregulation of ACh is sufficient to reverse memory deficits. For instance, systemic administration of cholinergic agonists reverses memory deficits produced by lesions of the septum or fornix (Maho et al. 1988; Hodges et al. 1991; Decker et al. 1992; Levin et al. 1993) . Memory enhancement can also sometimes be observed in the absence of a pre-existing deficit (Aigner and Mishkin 1986; Levin et al. 1993 ). More importantly, direct hippocampal infusions have similar effects. Specifically, hippocampal or entorhinal infusions of physostigmine, which blocks ACh degradation by inhibiting acetylcholinesterase (AChE), reverse memory deficits produced by septal infusions of the GABA-A agonist muscimol Parent 2000, 2001) . Also, in rats given septal infusions of muscimol, intrahippocampal infusions of glucose increase hippocampal extracellular ACh (Degroot et al. 2003) and reverse memory deficits (Parent et al. 1997) . Similarly, sustained hippocampal infusion of a cholinergic agonist improves memory in rats with bilateral fornix lesions (Howard III et al. 1989) .
It is important to emphasize that the fact that a compound can reverse a deficit does not necessarily indicate this compound is acting at the substrate that produces the deficit. For instance, the fact that hippocampal infusions of an AChE inhibitor reverse deficits produced by septal GABA receptor activation does not necessarily imply that the GABA-induced deficit is mediated via an effect on ACh. It means only that elevating ACh is sufficient to overcome the deficit, perhaps, for example, by increasing compensatory responses (Björklund and Dunnett 1995) . Indeed, the hypothesis that septal GABA receptor activation impairs memory exclusively via an effect on hippocampal ACh is not supported by the finding that septal infusions of muscimol still impair memory when the septohippocampal cholinergic projection is lesioned (Pang and Nocera 1999) . On the other hand, a wealth of evidence indicates that septal GABA receptor activation does likely impair memory through a process that involves, at least in part, inhibition of hippocampal ACh. Septal infusions of muscimol decrease a variety of measures of hippocampal ACh (Blaker et al. 1983; Costa et al. 1983; Brioni et al. 1990; Gorman et al. 1994; Moor et al. 1998a ), prevent training-or handling-induced increases in hippocampal ACh (Durkin 1992; Moor et al. 1998b) , and modulate the dose-response properties of hippocampal infusions of cholinergic agonists on memory (Farr et al. 1999) . Also, only those doses of muscimol that impair memory affect hippocampal ACh (Brioni et al. 1990 ).
To summarize, correlations between cholinergic activity and memory, and the ability of cholinergic agents to reverse memory deficits suggest that hippocampal ACh is involved in normal memory function. However, none of this evidence bears on the question of whether hippocampal ACh is necessary for memory. Two primary approaches have been used to address this question: first, pharmacological blockade of ACh receptors in the hippocampus, and second, direct lesions of septal cholinergic neurons. Data from studies using pharmacological approaches suggest that hippocampal ACh is necessary for normal memory, whereas data from studies of selective lesions of septal cholinergic neurons suggest that these neurons are not essential.
Evidence For and Against a Necessary Role of the Cholinergic System in Memory
Antagonism of Hippocampal ACh
The amnestic properties of anticholinergic drugs such as scopolamine and atropine have long been known (e.g., Drachman and Leavitt 1974) . Systemic administration of scopolamine impairs hippocampal-dependent learning and memory in rats (Eckerman et al. 1980; Stevens 1981; Decker and Gallagher 1987) . These drug effects on behavior could be mediated by structures outside the hippocampus, because ACh receptors are located throughout the central nervous system, including the hippocampus, neocortex, amygdala, thalamus, and striatum (Mash and Potter 1986; Perry and Kellar 1995) . The possibility that systemic scopolamine affects memory via effects on non-hippocampal structures is supported by the finding that scopolamine can still impair memory in animals with hippocampal lesions (Richmond et al. 1997; Wan et al. 1997) .
Studies that examine the effects of infusing cholinergic antagonists directly into the hippocampus bear more directly on the question of whether hippocampal cholinergic neurotransmission is necessary for learning and memory processes. Although these studies are fewer in number relative to studies of systemic anticholinergic drugs, the results of these studies indicate that intrahippocampal infusion of muscarinic antagonists (Brito et al. 1983; Izquierdo et al. 1992; Kim and Levin 1996; Carli et al. 1997 Carli et al. , 2000 Ohno et al. 1997a,b; Gale et al. 2001; Wallenstein and Vago 2001) or nicotinic antagonists (Ohno et al. 1993; Felix and Levin 1997; Levin et al. 2002) consistently impair hippocampal-dependent memory. Combined, these findings indicate that hippocampal ACh is essential for normal memory function.
Lesions of the Medial Septum or Its Projections
Lesions of the fimbria-fornix, or electrolytic or neurotoxic lesions of the medial septum, impair hippocampal-dependent learning and memory (Mahut 1972; Olton et al. 1978; Mitchell et al. 1982; Rawlins and Olton 1982; Hepler et al. 1985; Kelsey and Landry 1988; Markowska et al. 1989; Kelsey and Vargas 1993) . These studies have been interpreted as supporting the hypothesis that hippocampal ACh is necessary for normal memory function. However, these lesions necessarily result in loss of both cholinergic and noncholinergic septohippocampal projections. Surprisingly, findings from experiments using the immunotoxin 192 IgG-saporin to produce selective lesions of cholinergic septohippocampal neurons often fail to cause any impairment in spatial learning in the water maze, spatial working memory in the radial arm maze, or contextual fear conditioning (Berger-Sweeney et al. 1994; Torres et al. 1994; Baxter et al. 1995 Dornan et al. 1996; McMahan et al. 1997; Chappell et al. 1998; Kirby and Rawlins 2003; Frick et al. 2004) . When impairments are observed after these selective lesions, they are rarely as great in magnitude as those observed after nonselective lesions of the septum or section of the fimbria-fornix. Thus, deficits observed after septal or fimbria-fornix lesions cannot be accounted for solely by the loss of hippocampal ACh. These latter findings have raised the unexpected possibility that hippocampal ACh is not essential for all types of hippocampal-dependent memory.
The data from 192 IgG-saporin lesions of basal forebrain cholinergic neurons are controversial, because many experiments failed to report significant behavioral impairments in common hippocampal-dependent learning and memory tasks following these lesions. However, nearly without exception, severe learning and memory impairments are found following i.c.v. administration of the toxin (Nilsson et al. 1992; BergerSweeney et al. 1994; Leanza et al. 1995 Leanza et al. , 1996 Waite et al. 1995; Walsh et al. 1995; LeBlanc et al. 1999; cf. Lehmann et al. 2000) . These impairments may be due to effects on motor performance or other variables rather than effects on memory (Waite et al. 1999; Lehmann et al. 2000) . Intraventricular 192 IgG-saporin lesions not only damage basal forebrain cholinergic neurons, but also cerebellar Purkinje cells Waite et al. 1995) , and the motor impairments following cerebellar damage are severe (Berger-Sweeney et al. 1994; Waite et al. 1995 Waite et al. , 1999 . They are also dependent on the dose of 192 IgG-saporin (Waite et al. 1995) , as would be expected if the neurotoxic action of the immunotoxin is mediated via an influence on cell populations outside the basal forebrain. The presence of concomitant cerebellar damage complicates the interpretation of results from these lesions as being due to a specific loss of basal forebrain cholinergic neurons, although some studies have addressed this problem by comparing effects of i.c.v. 192 IgG-saporin with those of i.c.v. OX7-saporin, a toxin that damages cerebellar Purkinje cells but not basal forebrain cholinergic neurons (Waite et al. 1999; Wrenn and Wiley 2001) . OX7-saporin lesions themselves can produce severe impairments in memory as well as in motor and sensory abilities (Waite et al. 1999; Gandhi et al. 2000) .
A few studies have used intraparenchymal injections of 192 IgG-saporin to produce large basal forebrain lesions that spare the cerebellum. These studies have found little (Frick et al. 2004) or no deficit Pizzo et al. 2002) in acquisition of spatial learning in the water maze or working memory in the radial arm maze (Vuckovich et al. 2004) , or have found that the deficits are associated with damage that is not specific to the basal forebrain (Perry et al. 2001) . Interestingly, some behavioral impairments are seen after combined damage to MS/VDB and nucleus basalis magnocellularis (NBM) cholinergic neurons that are not observed after lesions of either projection alone (Baxter et al. 1999a; Pizzo et al. 2002) . These findings suggest that septohippocampal cholinergic projections may be capable of supporting memory when damage to other systems is present. These results also raise the possibility that both the basalocortical and septohippocampal projections may need to be compromised in order to produce a spatial deficit in those instances when only ACh neurons are lesioned. Such a requirement could account for the finding that systemic cholinergic antagonists impair spatial memory.
Some studies have reported significant impairment in spatial learning and memory following selective 192 IgG-saporin lesions of the MS/VDB (Shen et al. 1996; Walsh et al. 1996; Pang et al. 2001; Cassel et al. 2002; Lehmann et al. 2002a Lehmann et al. ,b, 2003 . However, the interpretation of these deficits as consequent to selective loss of cholinergic MS/VDB neurons is sometimes questionable. In many cases, these studies have used high doses of 192 IgG-saporin and/or injection protocols that may compromise noncholinergic MS/VDB neurons. Importantly, they have not presented histological verification of the integrity of GABAergic projection neurons at the lesion site (see also McMahan et al. 1997; Chappell et al. 1998 ; Baxter 2001 for discussion).
There are instances when selective 192 IgG-saporin lesions of the MS/VDB produce deficits, and the integrity of GABAergic projection neurons at the lesion site is documented. It is important to note that when memory deficits are reported after damage limited to septohippocampal cholinergic projections, those deficits are often smaller in comparison to deficits observed after damage to the hippocampus or fornix, or after systemic cholinergic blockade. This suggests that when a spatial memory test does exert a specific requirement on septohippocampal cholinergic projections, this requirement is limited. Furthermore, when impairments are seen in memory tasks after cholinergic lesions, they may be caused by an influence on a nonmnemonic process. Lehmann and colleagues (2003) found that 192 IgG-saporin lesions of the MS/VDB induced prior to training in a spatial radial arm maze task impaired acquisition performance. However, because the lesions were induced before training, further studies are needed to determine whether the deficits reflect a spatial learning deficit or an impairment in another process, such as a component of attention. Cholinergic MS/VDB lesions produce a delay-independent impairment in matching-to-place in the water maze, although the deficit may be attentional because it does not vary with the training-retention interval (Baxter et al. 1995) . Impairments have also been reported in acquisition and performance of a delayed matching-to-place task in the T-maze (Gibbs 2002; Johnson et al. 2002) following lesions limited to MS/VDB cholinergic neurons. However, nonmatching-to-place in the Tmaze is not impaired following MS/VDB cholinergic lesions (Pang and Nocera 1999; Kirby and Rawlins 2003) . Because the memory requirement in the two tasks is equivalent, the matching deficits may reflect an inability to apply a behavioral rule that is contrary to the rat's spontaneous nonmatching behavior, rather than an impairment in spatial memory per se.
Selective septohippocampal ACh lesions also produce retrograde amnesia for socially transmitted food preferences, a form of nonspatial paired-associate learning (Vale-Martínez et al. 2002) . These lesions also impair memory for postoperatively learned associations if learning is made difficult by presenting only a single acquisition trial (Berger-Sweeney et al. 2000) or by increasing the number of choice alternatives at the retention test, which possibly reflects a retrieval deficit (Vale-Martínez et al. 2002) . However, because intact learning and memory for these associations can also be observed in some test situations (Vale-Martínez et al. 2002) , it seems that cholinergic input to the hippocampus is not always essential for this form of paired-associate learning. Impairments in conditional associative learning tasks are also seen after lesions of MS/VDB cholinergic neurons (Ridley et al. 1999; Janisiewicz et al. 2004 ). However, when conditional tasks are presented with computer-graphic, two-dimensional stimuli, impairments in visual-spatial conditional learning are not observed consistently, and their presence appears to reflect an impairment in the transfer of behavioral rules from previously learned discrimination problems (Janisiewicz and Baxter 2003) . Taken together, these findings imply that selective damage to cholinergic afferents to the hippocampus can affect memory and other aspects of cognitive processing, but these deficits are limited to a subset of cognitive processes dependent on the hippocampus. Indeed, it is not surprising that selective damage to a subset of hippocampal afferents does not produce an effect equivalent to that of a hippocampal lesion. We speculate on the possible specific role(s) of hippocampal ACh in a later section.
Can Compensation or Insufficient Lesion Size Explain Negative Effects of 192 IgG-saporin Lesions?
Because the finding that lesions limited to septohippocampal cholinergic projections produce minimal deficits in spatial learning and memory is at odds with the evidence reviewed above in favor of a role of hippocampal ACh in memory, it is essential to rule out the possibility that there is a methodological problem with the 192 IgG-saporin data. Given that these studies involve lesions, they assume the same limitations of any lesion study. Specifically, the absence of a lesion effect could be due to the possibility that the lesion was not extensive enough to produce a behavioral effect, that normal memory is mediated by compensatory changes produced by the lesions, or both.
192 IgG-saporin lesions of the MS/VDB do not produce complete destruction of hippocampal ACh. Hippocampal ChAT is commonly used as a quantitative measure of lesion extent, although histochemistry for AChE has also been employed (McGaughy et al. 1996; Wrenn et al. 1999 ). These enzyme measures correlate positively with the number of basal forebrain neurons remaining after the lesion (Leanza et al. 1995; Wrenn et al. 1999; McGaughy et al. 2002) . However, because neither enzyme is the rate-limiting step for ACh synthesis or release, it is possible that ChAT and AChE measures overestimate the functional extent of the lesion. Studies examining the effects of 192 IgG-saporin lesions of the MS/VDB commonly report 70%-90% loss of hippocampal ChAT activity, reflecting a loss of cholinergic terminals. This 90% may reflect the sensitivity limit of the assay, or it may indicate that some projections remain and could mediate the spared retention that is observed in rats given 192 IgG-saporin lesions of the MS/VDB. There are data suggesting that ACh syn-thesis in remaining neural elements in the hippocampus may increase to compensate for the loss of projections (Waite and Chen 2001; Chang and Gold 2002) . However, there is also evidence to the contrary indicating that 192 IgG-saporin lesions virtually abolish evoked ACh release from hippocampal slices (Birthelmer et al. 2002 (Birthelmer et al. , 2003 . As in the case of fimbria-fornix lesions (Westlind et al. 1981; Dawson et al. 1989) , selective septohippocampal ACh lesions may also produce an increase in the number of postsynaptic muscarinic receptors (Roßner et al. 1995; Sorger et al. 1999; cf. Potter et al. 1999 ). Another possibility is that compensation occurs through the engagement of other neurotransmitter or neural systems, which could substitute for the deficiency in hippocampal ACh. Also, there are intrinsic cholinergic interneurons in the hippocampus (Frotscher et al. 1986; Frotscher 1988 ) that would not likely be affected by MS/VDB infusions of 192 IgG-saporin. However, these neurons do not appear to compensate for the loss of cholinergic input to the hippocampus that follows fimbria-fornix section (Frotscher 1988) , so presumably they also would not compensate following loss of cholinergic input due to 192 IgG-saporin lesions.
There are several lines of evidence that suggest that insufficient lesion size or compensatory reorganization cannot account for the normal memory observed in animals with selective cholinergic lesions. First, nonspecific neurotoxic lesions which damage both noncholinergic and cholinergic septal neurons impair memory, yet produce less depletion of hippocampal ACh than do the selective lesions. For instance, Hagan et al. (1988) reported impairments in spatial learning in rats with ibotenic acid lesions of the medial septum that reduced hippocampal ChAT activity by 70%. In contrast, Baxter et al. (1995) found no impairment in spatial learning in rats with immunolesions of the MS/VDB that reduced hippocampal ChAT activity by 90%.
Second, it is also not clear how either compensation or insufficient lesion magnitude can account for the finding that cholinergic septal lesions are capable of producing significant behavioral impairments in other measures. For example, removal of septohippocampal cholinergic neurons impairs latent inhibition, which indexes the ability to reduce attention to a pre-exposed stimulus. Furthermore, the impairment produced by the cholinergic lesions is as severe as that produced by neurotoxic hippocampal lesions (Han et al. 1995; . Similar deficits are observed in other paradigms that assess the ability to reduce attention to conditioned stimuli (Baxter et al. , 1999c . The instances in which lesions are and are not effective cannot be accounted for by between-subject differences because the same rats that are impaired in the latent inhibition test did not have any deficits in a previous test of spatial memory in the Morris water maze (Baxter et al. 1995) . Compensation would be expected to produce the opposite pattern, with tests given closer to the time of the lesion showing greater impairment than tests given later. It is also not clear how compensation and insufficient lesion size could affect some hippocampal-dependent tasks and not others. The possibility remains, though, that spatial cognition is more resilient to loss of hippocampal cholinergic input than are other functions of the hippocampus. Combined, these findings indicate that it is unlikely that selective cholinergic lesions do not impair memory because they do not produce a threshold depletion of ACh, or because the lesions produce compensatory reorganization that mediates the spared memory. Moreover, these findings suggest that the impairment seen after nonspecific neurotoxic lesions cannot solely be due to the loss of cholinergic neurons, even though much of the data from neurotoxic lesion experiments were interpreted in this way initially. They also support the hypothesis that there is only a subset of hippocampal-dependent tasks that require ACh to be performed efficiently.
To resolve definitively the question of necessity of cholinergic MS/VDB neurons in memory would require the ability to selectively and reversibly inactivate cholinergic neurons in the MS/VDB, but there is apparently currently no means of doing this. Such experiments would address the question of whether 192 IgG-saporin lesions typically fail to impair memory because the permanent nature of the lesion permits the development of compensatory changes. Although studies of intraseptal infusions of cholinergic agents are often discussed in the context of their effects on cholinergic neurons, muscarinic receptors are present on both cholinergic and GABAergic projection neurons (Van der Zee and Luiten 1994; Levey et al. 1995; Rouse and Levey 1996) . Moreover, muscarinic agents seem to predominantly modulate GABAergic projections from the MS/VDB to the hippocampus rather than the cholinergic projection (Alreja et al. 2000b; Wu et al. 2000) . Therefore, these studies shed little light on the question of whether septohippocampal cholinergic projections are necessary for learning and memory. Another important strategy would be to systematically characterize the functional capacity of hippocampal ACh following 192 IgG-saporin lesions of cholinergic projections to the hippocampus. For example, it would be useful to combine in vivo microdialysis procedures with behavioral analyses in 192 IgG saporin-lesioned rats to examine the extent to which ACh release occurs in memory tasks that are and are not impaired by the lesions. Some progress has already been made in this regard; Chang and Gold (2002) reported some preliminary findings indicating that rats with 192 IgG-saporin lesions of the MS/VDB were impaired on spontaneous alternation, but that there was residual hippocampal ACh release in these rats. In fact, the behaviorally induced increase in ACh relative to baseline was higher in lesioned rats than in controls.
DISCUSSION
We have discussed evidence that the presence of hippocampal ACh is sufficient to support many forms of learning and memory following disruption of the septohippocampal system. Furthermore, changes in hippocampal cholinergic markers and memory are frequently highly correlated with one another. These findings indicate that hippocampal ACh is involved in memory or at the very least, that it has the capacity to participate. However, septohippocampal cholinergic neurons do not appear to be necessary for many aspects of hippocampal-dependent memory, as performance on many spatial learning and memory tasks survives the loss of these neurons. Rather than discounting the data from 192 IgG-saporin lesions because they are not congruent with observations made from other experimental approaches, we suggest that they can be viewed as contributing to the specific question of whether cholinergic neurons are necessary for memory function, and for which functions they may be necessary. This distinction between necessity and sufficiency/ involvement is hardly a novel one (e.g., Berntson et al. 1996; Martin et al. 2000) , but it has not been widely considered in analyses of the role of septohippocampal ACh in memory (cf. Pang and Nocera 1999; Baxter and Murg 2002; McIntyre et al. 2002) .
Remaining Issues
One question that remains is the mismatch between the effects of infusions of cholinergic antagonists into the hippocampus, which impair memory, versus the effects of selective lesions of MS/VDB cholinergic neurons, which remove cholinergic projections to the hippocampus but produce limited effects on learning and memory. It is remarkable that infusions of cholinergic antagonists into the hippocampus can produce such large deficits in memory. Experiments with neurotoxic lesions of the hippo-
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www.learnmem.org campus suggest that at least 20% of hippocampal volume must be damaged to produce spatial learning impairments (Moser et al. 1993 ), yet cholinergic antagonists produce deficits while having a more spatially and temporally limited effect on hippocampal function than do lesions. One possibility is that intrahippocampal drug infusions exert effects that are not limited to cholinergic receptor blockade. For example, they may produce a local anesthetic effect or disrupt other neurotransmitter systems, although there is apparently no evidence for these possibilities. Another possibility is that disturbance of a limited area of the hippocampus is more deleterious to memory than large-scale disruption (Solomon et al. 1983; Baxter and Murray 2001) . That is, the output of a dysfunctional hippocampus may produce more cognitive deficits than would the absence of hippocampal processing. Finally, the discrepancy between the effects of antagonists and lesions could reflect compensatory changes that occur with permanent lesions but not with transient pharmacological manipulations. However, we have already discussed the evidence indicating why this is not a likely explanation.
It is possible that the absence of impairment in spatial learning tasks (such as the radial arm maze or water maze) following lesions of MS/VDB cholinergic neurons reflects the fact that there are multiple strategies available for correctly solving these tasks, only some of which are affected by removal of hippocampal cholinergic input. This may make spatial learning tasks more resistant to the loss of hippocampal cholinergic input, relative to other behaviors that may specifically require a certain aspect of hippocampal-dependent information processing such as decreases in the associability of conditioned stimuli (Baxter et al. , 1999c . For example, rats may use egocentric (body movement) cues, path integration, orientation to single visual cues, spatial maps, or any combination thereof to solve such problems (Whishaw et al. 1995; Dudchenko et al. 1997; Martin et al. 1997; Dudchenko 2001) . Two studies have suggested that lesions of MS/ VDB cholinergic neurons bias rats away from using an allocentric (place) strategy to solve a radial arm maze (Janis et al. 1998; Lehmann et al. 2003) , although other studies have found that rats with these lesions are able to use such strategies in the crossmaze (Cahill and Baxter 2001) or water maze . Examination of particular strategies used by animals to solve spatial problems might represent a fruitful avenue of investigation, as selective neurochemical lesions may be able to reveal how spatial cognition is fractionated within the hippocampus.
The involvement of noncholinergic septohippocampal projections in memory remains unspecified. Electrophysiological studies show that muscarinic agonists and antagonists and opioid agonists preferentially act at the septohippocampal GABAergic projection (Alreja et al. 2000a,b; Wu et al. 2000) . These findings suggest that infusions of these agents into the medial septum may exert their effects on memory by affecting GABAergic rather than cholinergic septohippocampal projections. However, it is worth noting that these studies are performed in brain slices from very young (2-4-wk-old) rats, so it will be important to confirm the physiology of the septohippocampal GABA projections in adult rats. Computational modeling suggests that GABA, acting via GABA(B) receptors, possesses the capacity to rapidly modulate hippocampal physiology on a time scale consistent with spatial learning (Wallenstein and Hasselmo 1997; Hasselmo and Fehlau 2001; Molyneaux and Hasselmo 2002) . Ibotenic acid lesions of the MS/VDB, which primarily affect the septal GABA neurons but spare the ACh neurons, impair place learning (Cahill and Baxter 2001) . In contrast, selective kainic acid-induced lesions of the septohippocampal GABA projection do not impair spatial learning, suggesting that the septal GABAergic projection is also not necessary for memory (Pang et al. 2001) . The discrepancy between the effects of GABA lesions in these latter two studies may be related to the presence of damage to the peptidergic component of the septohippocampal projection, which was not assessed. Indeed, the contributions of the peptidergic and putative glutamatergic septohippocampal projections to memory warrant further investigation. The combined findings that fornix lesions impair memory and that selective cholinergic and GABAergic septal lesions do not raise the possibility that combined damage to cholinergic and noncholinergic septal projection neurons might be necessary to impair hippocampaldependent memory. In support of this, selective lesions of the septal GABA projection do impair memory when combined with 192 IgG-saporin lesions of the cholinergic projection (Pang et al. 2001) .
Attentional deficits are reliably observed after selective loss of basal forebrain cholinergic neurons, both in the MS/VDB and in the NBM/substantia inominata (McGaughy et al. 1996 (McGaughy et al. , 2002 Baxter et al. , 1999c Sarter et al. 1997 Sarter et al. , 1999 McGaughy and Sarter 1998) . Subtle effects of ACh on memory could be mediated by changes in attentional processing, and this may help explain some of the inconsistencies. Lesions of corticopetal cholinergic projections (from the NBM) also often impair performance on a variety of attentional tasks (McGaughy et al. 1996 (McGaughy et al. , 2002 Lehmann et al. 2003) without substantially affecting memory (e.g., Baxter et al. 1995; Dornan et al. 1996; Galani et al. 2002) . These findings indicate that impairments in attention following basal forebrain cholinergic lesions must exert relatively circumscribed effects on the overall efficiency of cognitive processing in order for learning and memory to proceed in the presence of impaired attentional processing. These lesions might be better characterized as disrupting the ability to regulate attentional resources, rather than the capacity to attend to stimuli per se (Baxter and Chiba 1999; Baxter and Murg 2002) . Memory tasks that include an increased burden on attention, or require a specific mode of information processing, should be more sensitive to loss of basal forebrain cholinergic neurons (e.g., Turchi and Sarter 2000) . However, the presence of dissociations between mnemonic and attentional performance following basal forebrain cholinergic damage suggests that many memory processes, which are involved in consolidation, storage, and retrieval, as well as encoding, can operate normally in the absence of cholinergic input (see also Sarter et al. 2003) . In the context of this discussion, it is important to be mindful that there are many different varieties of attentional processing, just as there are different systems for different kinds of memory (Muir 1996; Bushnell 1998; Sarter and McGaughy 1998) . Thus, the demonstration of a dissociation between a particular aspect of attentional processing and memory performance following septohippocampal ACh lesions (e.g., Lehmann et al. 2003) does not necessarily imply that other aspects of attention are also intact following the lesions (cf. Baxter et al. , 1999c .
Conclusion
In summary, the findings that cholinergic activity in the hippocampus is correlated with memory, and restoration of ACh in the hippocampus after disruption of the septohippocampal pathway is sufficient to rescue memory, indicate that hippocampal ACh is involved in memory. However, selective ablation of cholinergic septohippocampal projections produces minimal effects on hippocampal-dependent learning and memory processes, suggesting that although hippocampal ACh may promote memory in the intact brain, it is not necessary for many aspects of hippocampal memory function.
These combined findings raise the possibility that hippocampal ACh may have a modulatory role in memory, analogous to the contributions of the amygdala. Amygdala activation enhances different types of memory (Packard et al. 1994; McGaugh et al. 2000) , yet lesions of the amygdala are without effect on many of the same tasks (McDonald and White 1993; Decker et al. 1995) . It has been suggested that like the amygdala, ACh in hippocampus and other brain regions may play a modulatory role in memory, perhaps coordinating the contributions of different memory systems (McIntyre et al. 2002 (McIntyre et al. , 2003 . Several lines of evidence are consistent with a modulatory role of hippocampal ACh. For instance, intrahippocampal infusions of ACh agonists enhance hippocampal-dependent memory (Izquierdo et al. 1992; Farr et al. 1999 Farr et al. , 2000 . Also, ACh increases the effectiveness of other inputs in stimulating action potentials in hippocampal neurons (for review, see Ridley et al. 1991) . Via hippocampal muscarinic receptors, ACh increases cytosolic calcium and amplifies action potential-induced calcium changes (Woolf 1996; Power and Sah 2002) . Notably, hippocampal muscarinic receptors are not necessary for long-term potentiation, but do facilitate it (Abe et al. 1994) . Thus, cholinergic systems may be engaged during learning and memory and may modulate memory, but learning and memory may proceed relatively normally in their absence.
The combined findings from studies examining the effects of 192 IgG-saporin lesions indicate that a small subset of hippocampal-dependent behavioral tasks are affected by the lesions. This raises the question of how to characterize the processes that require hippocampal ACh. One possibility is that hippocampal ACh may lend flexibility to higher-order learning, such as the application of behavioral rules and transfer of experience across behavioral problems (Sarter et al. 2002; Janisiewicz and Baxter 2003) . Thus, it may be generally involved in the flexibility of memory expression in the hippocampal system (Reber et al. 1996; Myers et al. 2002) . Further evidence in support of this view comes from studies of place cell activity in the hippocampus after 192 IgG-saporin lesions of the MS/VDB. Place cells in rats with cholinergic lesions show equivalent electrophysiological properties and spatial selectivity, but their spatial firing patterns are less flexible than those of controls when the local environment is altered (Ikonen et al. 2002) . It is worth noting that this place cell inflexibility does not seem to be related to spatial learning impairments in rats with similar lesions (Baxter et al. 1995; Janisiewicz et al. 2004 ). This role for hippocampal ACh in flexibility of memory representations might also be related to a general role for ACh in restructuring cortical sensory and motor representations as a consequence of learning (Bakin and Weinberger 1996; Kilgard and Merzenich 1998; Conner et al. 2003) .
These views have implications for understanding the role of cholinergic deficiency in disorders of memory, including Alzheimer's disease (Davies 1999; Davis et al. 1999) , as well as for the ability of cholinergic drug therapies to improve memory Bartus 2000) . Because loss of cholinergic neurons does not seem to be a sufficient basis to explain memory impairment in normal aging or neurodegenerative disease, other neurobiological substrates of this decline must be identified Rosenzweig and Barnes 2003) . Understanding how these other mechanisms might be necessary for memory may lead to new therapies for memory impairment. Consideration of the mechanisms by which hippocampal ACh can modulate memory, and the aspects of memory for which it may be necessary, may also lead to new strategies for memory improvement, as well as to a better understanding of the fundamental neurobiology of memory function in the hippocampus.
